Table 2.
Single element WSS95 performance.
| SR report topic | TI | AB | PT | AU | MH |
| ACE inhibitors | 76.49 | 71.07 | 33.22 | 0 | 47.37 |
| ADHD | 80.26 | 65.10 | 22.56 | 0 | 47.00 |
| Antihistamines | 13.55 | 15.81 | 32.58 | 0 | 2.58 |
| Atypical antipsychotics | 17.23 | 20.54 | 19.64 | 0 | 9.46 |
| Beta blockers | 44.74 | 49.95 | 43.77 | 0 | 28.67 |
| Calcium channel blockers | 19.38 | 16.34 | 18.64 | 0 | 20.94 |
| Estrogens | 29.35 | 29.08 | 17.93 | 0 | 38.59 |
| NSAIDS | 63.36 | 66.67 | 58.27 | 0 | 33.84 |
| Opioids | 8.30 | 9.82 | 37.23 | 0 | 6.48 |
| Oral hypoglycemics | 11.73 | 12.13 | 22.27 | 0 | 7.55 |
| Proton pump inhibitors | 43.74 | 15.60 | 35.48 | 0 | 20.56 |
| Skeletal muscle relaxants | 0 | 36.03 | 74.68 | 0 | 42.85 |
| Statins | 25.52 | 30.17 | 13.31 | 0 | 13.68 |
| Triptans | 45.60 | 42.47 | 28.17 | 0 | 33.23 |
| Urinary incontinence | 30.89 | 18.65 | 43.43 | 0 | 26.91 |
| Average WSS95 | 34.01 | 33.30 | 33.41 | 0 | 25.31 |